| 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with … MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ... European journal of cancer 47 (1), 8-32, 2011 | 1244 | 2011 |
| Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients J Bohlius, J Wilson, J Seidenfeld, M Piper, G Schwarzer, J Sandercock, ... Journal of the National Cancer Institute 98 (10), 708-714, 2006 | 829 | 2006 |
| Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials J Bohlius, K Schmidlin, C Brillant, G Schwarzer, S Trelle, J Seidenfeld, ... The Lancet 373 (9674), 1532-1542, 2009 | 723 | 2009 |
| EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and … MS Aapro, DA Cameron, R Pettengell, J Bohlius, J Crawford, M Ellis, ... European journal of cancer 42 (15), 2433-2453, 2006 | 651 | 2006 |
| Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis H Schulz, JF Bohlius, S Trelle, N Skoetz, M Reiser, T Kober, G Schwarzer, ... Journal of the National Cancer Institute 99 (9), 706-714, 2007 | 463 | 2007 |
| Erythropoietin or darbepoetin for patients with cancer J Bohlius, J Wilson, J Seidenfeld, M Piper, G Schwarzer, J Sandercock, ... Cochrane Database of Systematic Reviews, 2006 | 441* | 2006 |
| A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research T Muka, M Glisic, J Milic, S Verhoog, J Bohlius, W Bramer, R Chowdhury, ... European journal of epidemiology 35, 49-60, 2020 | 352 | 2020 |
| Erythropoietin or darbepoetin for patients with cancer T Tonia, A Mettler, N Robert, G Schwarzer, J Seidenfeld, O Weingart, ... Cochrane Database of Systematic Reviews, 2012 | 337 | 2012 |
| Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis J Bohlius, S Langensiepen, G Schwarzer, J Seidenfeld, M Piper, ... Journal of the National Cancer Institute 97 (7), 489-498, 2005 | 318 | 2005 |
| Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update JD Rizzo, MR Somerfield, KL Hagerty, J Seidenfeld, J Bohlius, CL Bennett, ... Journal of Clinical Oncology 26 (1), 132-149, 2008 | 316 | 2008 |
| KDIGO clinical practice guideline for anemia in chronic kidney disease К Анемії Kidney Int 2, 279, 2012 | 276 | 2012 |
| American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer JD Rizzo, M Brouwers, P Hurley, J Seidenfeld, MO Arcasoy, JL Spivak, ... Blood, The Journal of the American Society of Hematology 116 (20), 4045-4059, 2010 | 266 | 2010 |
| Granulopoiesis‐stimulating factors to prevent adverse effects in the treatment of malignant lymphoma J Bohlius, C Herbst, M Reiser, G Schwarzer, A Engert Cochrane Database of Systematic Reviews, 2008 | 239 | 2008 |
| Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis P Koehler, M Stecher, OA Cornely, D Koehler, MJGT Vehreschild, ... Clinical microbiology and infection 25 (10), 1200-1212, 2019 | 222 | 2019 |
| American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer JD Rizzo, M Brouwers, P Hurley, J Seidenfeld, MO Arcasoy, JL Spivak, ... Journal of clinical oncology 28 (33), 4996-5010, 2010 | 208 | 2010 |
| European Organisation for Research and Treatment of Cancer. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of … MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ... Eur J Cancer 47 (1), 8-32, 2011 | 207 | 2011 |
| The erythropoietin receptor in normal and cancer tissues W Jelkmann, J Bohlius, M Hallek, AJ Sytkowski Critical reviews in oncology/hematology 67 (1), 39-61, 2008 | 206 | 2008 |
| A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment J Wilson, GL Yao, J Raftery, J Bohlius, S Brunskill, J Sandercock, ... NIHR Health Technology Assessment programme: Executive Summaries, 2007 | 203 | 2007 |
| Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ... Blood advances 3 (8), 1197-1210, 2019 | 200 | 2019 |
| Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update JD Rizzo, MR Somerfield, KL Hagerty, J Seidenfeld, J Bohlius, CL Bennett, ... Blood, The Journal of the American Society of Hematology 111 (1), 25-41, 2008 | 167 | 2008 |
Guido SchwarzerInstitute of Medical Biometry and Statistics, University of FreiburgVerified email at imbi.uni-freiburg.de
